Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Eloi Chevallier"'
Autor:
Carla Vela, Thomas Jouve, Eloi Chevallier, Farida Imerzoukene, Raphaële Germi, Marion Le Marechal, Aurélie Truffot, Gaëlle Fiard, Bénédicte Janbon, Diane Giovannini, Paolo Malvezzi, Lionel Rostaing, Johan Noble
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 24; Pages: 7292
BK virus-associated nephropathy (PvAN) increases the risk of graft failure justifying treatment. Conversion to mammalian target of rapamycin inhibitors (mTORi) and Human polyclonal immunoglobulins (IVIg) could prevent the risk of PvAN. Our retrospect
Autor:
Landry Seyve, Lionel Rostaing, Florian Terrec, Lionel Motte, Hamza Naciri Bennani, Eloi Chevallier, Johan Noble, Thomas Jouve, Raphaël Marlu, Paolo Malvezzi
Publikováno v:
Journal of Clinical Apheresis. 36:766-774
Background Double-filtration plasmapheresis (DFPP), a selective therapeutic apheresis, can deplete pathogenic antibodies/substances, but also important coagulation factors. Aim To determine if the use of a separator filter with different characterist
Autor:
Lionel Motte, Lionel Rostaing, Farida Imerzoukene, Thomas Jouve, Raphaël Marlu, Johan Noble, Paolo Malvezzi, Eloi Chevallier, Hamza Naciri Bennani
Publikováno v:
Journal of Clinical Apheresis. 36:574-583
BACKGROUND Fibrinogen reconstitution after therapeutic apheresis has been poorly studied. Apheresis modalities, for example, plasma exchange (PE), double-filtration plasmapheresis (DFPP), or selective immunoadsorption (IA), may have different impacts
Autor:
Lionel Rostaing, Landry Seyve, Lionel Motte, Eloi Chevallier, Farida Imerzoukene, Hamza Naciri Bennani, Mathilde Bugnazet, Johan Noble, Paolo Malvezzi, Maryvonne Christophe, Thomas Jouve, Raphaël Marlu
Publikováno v:
Journal of Clinical Apheresis. 36:408-419
BACKGROUND Plasmapheresis can deplete pathogenic antibodies and allow ABO- and/or HLA-incompatible transplantation. AIM To determine the impacts of three modalities of plasmapheresis (centrifugal plasmapheresis [cTPE], single-filtration plasmapheresi
Autor:
Thomas Jouve, Emmeline Lagrange, Eloi Chevallier, Paolo Malvezzi, Lionel Rostaing, Hamza Naciri Bennani, Johan Noble, Lionel Motte
Publikováno v:
Journal of Clinical Apheresis. 36:348-363
Introduction Myasthenia gravis (MG) is an autoimmune disease mediated by circulating autoantibodies (anti-AchR, anti-MuSK, etc.). More than 20% of myasthenic patients are refractory to conventional treatments (plasma exchange, IVIg, steroids, azathio
Publikováno v:
Expert Review of Clinical Pharmacology. 14:55-66
Preexisting diabetes (PD) and post-transplant diabetes mellitus (PTDM) are common and severe comorbidities posttransplantation. The immunosuppressive regimens are modifiable risk factors.We reviewed Pubmed and Cochrane database and we summarize the m
Autor:
Nicolas Bouvier, Yannick Le Meur, Cyril Garrouste, Dominique Bertrand, Johnny Sayegh, Eloi Chevallier, Matthias Büchler, Sophie Caillard, Joseph Rivalan, Antoine Thierry, Lionel Rostaing, Philippe Gatault, Charlotte Colosio, Jean-Philippe Rerolle
Publikováno v:
Transplantation Proceedings
Transplantation Proceedings, 2020, 52 (10), pp.3179-3185. ⟨10.1016/j.transproceed.2020.06.005⟩
Transplantation Proceedings, 2020, 52 (10), pp.3179-3185. ⟨10.1016/j.transproceed.2020.06.005⟩
Kidney transplant recipients (KTRs) are frequently infected with chronic hepatitis C virus (HCV), which can increase the risk of graft loss. Active HCV infections among KTRs are associated with shorter survival times. The emergence of very efficient
Autor:
Thomas Jouve, Bénédicte Janbon, Johan Noble, Claudine Giroux-Lathuile, Paolo Malvezzi, Eloi Chevallier, Farida Imerzoukene, Lionel Rostaing, Hamza Naciri Bennani, Mathilde Bugnazet, Florian Terrec, Lionel Motte
Publikováno v:
Journal of Clinical Apheresis. 36:149-160
Introduction ABO-incompatible (ABOi) kidney transplantation, a well-established procedure, has good long-term results provided pretransplant desensitization that includes immunosuppression and apheresis. Objective To compare, within the first pretran
Autor:
Lionel Rostaing, Paolo Malvezzi, Louis Manière, Eloi Chevallier, Farida Imerzoukene, Florian Terrec, Hamza Naciri Bennani, Raphaele Germi, Mathilde Bugnazet, Thomas Jouve, Johan Noble, Bénédicte Janbon
Publikováno v:
International Urology and Nephrology. 53:591-600
To compare everolimus (EVR) plus low-dose tacrolimus (TAC) with mycophenolic acid (MPA) plus standard-dose TAC with regards to rates of cytomegalovirus (CMV) disease in de novo kidney-transplant recipients (KTRs). This single-center retrospective stu
Autor:
Thomas Jouve, Lionel Motte, Hamza Naciri Bennani, Eloi Chevallier, Landry Seyve, Johan Noble, Maryvonne Christophe, Lionel Rostaing, Raphaël Marlu, Paolo Malvezzi, Bénédicte Janbon, Farida Imerzoukene
Publikováno v:
Journal of Clinical Apheresis. 35:444-452
INTRODUCTION ABO- or HLA-incompatible kidney transplantation is possible thanks to pretransplant antibody-depletion achieved by extracorporeal-treatment modalities. These methods induce depletion of some plasma proteins and may also impact on protein